Antimicrobial activity of solithromycin against serotyped macrolide-resistant streptococcus pneumoniae isolates collected from U.S. medical centers in 2012

Antimicrobial Agents and Chemotherapy

Volumn 59, Issue 4, 2015, Pages 2432-2434

  Farrell, D J ^a   Mendes, R E ^a   Jones, R N ^a  

^a JMI LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MACROLIDE; SOLITHROMYCIN; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; CPSB PROTEIN, STREPTOCOCCUS PNEUMONIAE; PROTEIN TYROSINE PHOSPHATASE; TRIAZOLE DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; DRUG POTENCY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; UNITED STATES; ANTIBIOTIC RESISTANCE; COMMUNITY ACQUIRED INFECTION; DRUG EFFECTS; GENETICS; HUMAN; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTIDRUG RESISTANCE; PENICILLIN RESISTANCE; PNEUMOCOCCAL INFECTION;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; MACROLIDES; MICROBIAL SENSITIVITY TESTS; PENICILLIN RESISTANCE; PNEUMOCOCCAL INFECTIONS; PROTEIN TYROSINE PHOSPHATASES; STREPTOCOCCUS PNEUMONIAE; TRIAZOLES; UNITED STATES;

EID: 84928902237     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.04568-14     Document Type: Article

References (11)

1. Whitney CG, Pilishvili T, Farley MM, Schaffner W, Craig AS, Lynfield R, Nyquist AC, Gershman KA, Vazquez M, Bennett NM, Reingold A, Thomas A, Glode MP, Zell ER, Jorgensen JH, Beall B, Schuchat A. 2006. Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study. Lancet 368: 1495-1502. http://dx.doi.org/10.1016/S0140-6736(06)69637-2.
2. Jacobs MR, Good CE, Bajaksouzian S, Windau AR. 2008. Emergence of Streptococcus pneumoniae serotypes 19A, 6C, and 22F and serogroup 15 in Cleveland, Ohio, in relation to introduction of the protein-conjugated pneumococcal vaccine. Clin Infect Dis 47:1388-1395. http://dx.doi.org/10.1086/592972.
3. Farrell DJ, Klugman KP, Pichichero M. 2007. Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States. Pediatr Infect Dis J 26:123-128. http://dx.doi.org/10.1097/01.inf.0000253059.84602.c3.
4. Richter SS, Heilmann KP, Dohrn CL, Riahi F, Diekema DJ, Doern GV. 2013. Pneumococcal serotypes before and after introduction of conjugate vaccines, United States, 1999-2011. Emerg Infect Dis 19:1074-1083. http://dx.doi.org/10.3201/eid1907.121830.
5. Farrell DJ, Sader HS, Castanheira M, Biedenbach DJ, Rhomberg PR, Jones RN. 2010. Antimicrobial characterisation of CEM-101 activity against respiratory tract pathogens, including multidrug-resistant pneumococcal serogroup 19A isolates. Int J Antimicrob Agents 35:537-543. http://dx.doi.org/10.1016/j.ijantimicag.2010.01.026.
6. McGhee P, Clark C, Kosowska-Shick KM, Nagai K, Dewasse B, Beachel L, Appelbaum PC. 2010. In vitro activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with defined macrolide resistance mechanisms. Antimicrob Agents Chemother 54:230-238. http://dx.doi.org/10.1128/AAC.01123-09.
7. Clinical and Laboratory Standards Institute. 2012. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard, 9th ed. CLSI document M07-A9. Clinical and Laboratory Standards Institute, Wayne, PA.
8. Clinical and Laboratory Standards Institute. 2014. Performance standards for antimicrobial susceptibility testing; 24th informational supplement. CLSI document M100-S24. Clinical and Laboratory Standards Institute, Wayne, PA.
9. Leung MH, Bryson K, Freystatter K, Pichon B, Edwards G, Charalambous BM, Gillespie SH. 2012. Sequetyping: serotyping Streptococcus pneumoniae by a single PCR sequencing strategy. J Clin Microbiol 50: 2419-2427. http://dx.doi.org/10.1128/JCM.06384-11.
10. Pai R, Gertz RE, Beall B. 2006. Sequential multiplex PCR approach for determining capsular serotypes of Streptococcus pneumoniae isolates. J Clin Microbiol 44:124-131. http://dx.doi.org/10.1128/JCM.44.1.124-131.2006.
11. Mendes RE, Costello AJ, Jacobs MR, Biek D, Critchley IA, Jones RN. 2014. Serotype distribution and antimicrobial susceptibility of USA Streptococcus pneumoniae isolates collected prior to and post introduction of 13-valent pneumococcal conjugate vaccine. Diagn Microbiol Infect Dis 80:19-25. http://dx.doi.org/10.1015/j.diagmicrobio.2014.05.020.